ROYAL BANK OF CANADA - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 80 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$61,000
+27.1%
35,599
+45.4%
0.00%
Q2 2023$48,000
-2.0%
24,476
+38.9%
0.00%
Q1 2023$49,000
-5.8%
17,627
+17.4%
0.00%
Q4 2022$52,000
-7.1%
15,019
-29.5%
0.00%
Q3 2022$56,000
+55.6%
21,289
+40.1%
0.00%
Q2 2022$36,000
-52.0%
15,200
-16.6%
0.00%
Q1 2022$75,000
-73.3%
18,226
-16.6%
0.00%
Q4 2021$281,000
+19.1%
21,846
+0.0%
0.00%
Q3 2021$236,000
+31.1%
21,845
+10.5%
0.00%
Q2 2021$180,000
+318.6%
19,774
+331.5%
0.00%
Q1 2021$43,000
+377.8%
4,583
+100.1%
0.00%
Q4 2020$9,0002,290
+14212.5%
0.00%
Q3 2020$0
-100.0%
16
-87.4%
0.00%
Q2 2020$1,000
-80.0%
127
-85.9%
0.00%
Q1 2020$5,000
-79.2%
900
-67.3%
0.00%
Q4 2019$24,000
-93.6%
2,750
-93.7%
0.00%
Q3 2019$375,000
-22.5%
43,425
-0.1%
0.00%
Q2 2019$484,000
+100.8%
43,469
+140.2%
0.00%
Q1 2019$241,000
+62.8%
18,100
+89.0%
0.00%
Q4 2018$148,0009,5750.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders